# SenesTech, Inc.: overview SNES · Nasdaq · CIK 1680378 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/snes.md) · [Financials](/companies/snes/financials.md) · [Filings](/companies/snes/filings.md) · [Insiders](/companies/snes/insiders.md) Latest reported revenue: [$770.0k](/filings/0001628280-26-053602.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-053602). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [482](/filings/0001628280-25-051177.md) | [501 d](/filings/0001628280-26-017384.md) | [485](/filings/0001628280-26-034244.md) | [625](/filings/0001628280-26-053602.md) | [690](/filings/0001628280-25-051177.md) | [421 d](/filings/0001628280-26-017384.md) | [493](/filings/0001628280-26-034244.md) | [770](/filings/0001628280-26-053602.md) | | Gross margin | % | [65.4%](/filings/0001628280-25-051177.md) | [60.9% d](/filings/0001628280-26-017384.md) | [64.5%](/filings/0001628280-26-034244.md) | [65.4%](/filings/0001628280-26-053602.md) | [62.8%](/filings/0001628280-25-051177.md) | [55.3% d](/filings/0001628280-26-017384.md) | [68.6%](/filings/0001628280-26-034244.md) | [73.6%](/filings/0001628280-26-053602.md) | | Operating margin | % | [(321.0%)](/filings/0001628280-25-051177.md) | [(250.9%) d](/filings/0001628280-26-017384.md) | [(342.9%)](/filings/0001628280-26-034244.md) | [(258.2%)](/filings/0001628280-26-053602.md) | [(195.2%)](/filings/0001628280-25-051177.md) | [(446.8%) d](/filings/0001628280-26-017384.md) | [(429.8%)](/filings/0001628280-26-034244.md) | [(241.8%)](/filings/0001628280-26-053602.md) | | Net margin | % | [(313.9%)](/filings/0001628280-25-051177.md) | [(250.5%) d](/filings/0001628280-26-017384.md) | [(343.3%)](/filings/0001628280-26-053602.md) | [(258.6%)](/filings/0001628280-26-053602.md) | [(188.1%)](/filings/0001628280-25-051177.md) | [(428.5%) d](/filings/0001628280-26-017384.md) | [(418.5%)](/filings/0001628280-26-053602.md) | [(237.9%)](/filings/0001628280-26-053602.md) | | Diluted EPS | $ per share | [(2.07)](/filings/0001628280-25-051177.md) | not reported | [(1.28)](/filings/0001628280-26-034244.md) | [(0.87)](/filings/0001628280-26-053602.md) | [(0.28)](/filings/0001628280-25-051177.md) | not reported | [(0.39)](/filings/0001628280-26-034244.md) | [(0.35)](/filings/0001628280-26-053602.md) | | Free cash flow | $k | [(1,427) d](/filings/0001628280-25-051177.md) | [(1,233) d](/filings/0001628280-26-017384.md) | [(1,593)](/filings/0001628280-26-034244.md) | [(1,197) d](/filings/0001628280-26-053602.md) | [(1,421) d](/filings/0001628280-25-051177.md) | [(1,677) d](/filings/0001628280-26-017384.md) | [(1,929)](/filings/0001628280-26-034244.md) | [(1,709) d](/filings/0001628280-26-053602.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [600](/filings/0001628280-23-008353.md) | [1,019](/filings/0001628280-24-005919.md) | [1,193](/filings/0001628280-25-012408.md) | [1,857](/filings/0001628280-26-017384.md) | [2,221](/filings/0001628280-26-017384.md) | | Gross margin | % | [40.7%](/filings/0001628280-23-008353.md) | [45.5%](/filings/0001628280-24-005919.md) | [45.2%](/filings/0001628280-25-012408.md) | [54.1%](/filings/0001628280-26-017384.md) | [62.5%](/filings/0001628280-26-017384.md) | | Operating margin | % | [(1489.0%)](/filings/0001628280-23-008353.md) | [(949.4%)](/filings/0001628280-24-005919.md) | [(648.1%)](/filings/0001628280-25-012408.md) | [(336.5%)](/filings/0001628280-26-017384.md) | [(292.9%)](/filings/0001628280-26-017384.md) | | Net margin | % | [(1378.0%)](/filings/0001628280-23-008353.md) | [(951.4%)](/filings/0001628280-24-005919.md) | [(646.3%)](/filings/0001628280-25-012408.md) | [(333.0%)](/filings/0001628280-26-017384.md) | [(287.4%)](/filings/0001628280-26-017384.md) | | Diluted EPS | $ per share | [(14.77)](/filings/0001628280-23-008353.md) | [(148.08)](/filings/0001628280-24-005919.md) | [(115.10)](/filings/0001628280-25-012408.md) | [(8.86)](/filings/0001628280-26-017384.md) | [(1.95)](/filings/0001628280-26-017384.md) | | Free cash flow | $k | [(7,879)](/filings/0001628280-23-008353.md) | [(8,751)](/filings/0001628280-24-005919.md) | [(7,715)](/filings/0001628280-25-012408.md) | [(6,117)](/filings/0001628280-26-017384.md) | [(5,888)](/filings/0001628280-26-017384.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/snes/insiders.md) | Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing | | --- | --- | --- | --- | ---: | ---: | ---: | --- | | 2026-10-22 | [Glenbrook Capital Management](/insiders/1273782.md) | 10% owner | Purchase (P) | 7,500 | $0.7986 | $6.0k | [Form 4](/filings/0000902664-26-004257.md) | | 2026-10-21 | [Glenbrook Capital Management](/insiders/1273782.md) | 10% owner | Purchase (P) | 60,000 | $0.7385 | $44.3k | [Form 4](/filings/0000902664-26-004257.md) | | 2026-10-20 | [Glenbrook Capital Management](/insiders/1273782.md) | 10% owner | Purchase (P) | 36,375 | $0.6746 | $24.5k | [Form 4](/filings/0000902664-26-004257.md) | ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [SABBY MANAGEMENT, LLC](/funds/1535610.md) | 2026-06-30 | $211.2k | 141,756 | | Reduced −76,777 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $123.1k | 82,616 | | Reduced −31,384 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $69.5k | 46,671 | | Added +35,352 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $66.1k | 44,339 | | Reduced −18,767 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $51.8k | 34,762 | | Reduced −8,103 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $39.6k | 26,594 | | Reduced −5,100 | | [ESSEX INVESTMENT MANAGEMENT CO LLC](/funds/201772.md) | 2026-06-30 | $39.0k | 26,203 | | Reduced −91 | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $26.2k | 17,587 | | New +17,587 | | [DIVERSIFY WEALTH MANAGEMENT, LLC](/funds/2030780.md) | 2026-06-30 | $25.4k | 19,119 | | Unchanged | | [Diversify Advisory Services, LLC](/funds/2021232.md) | 2026-06-30 | $25.4k | 19,119 | | New +19,119 | ## Recent filings [All 647 filings](/companies/snes/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-30 | 21:06 ET | [SCHEDULE 13D/A](/filings/0001731122-26-001384.md) | Ownership report, active investor, amended | 0001731122-26-001384 | | 2026-10-26 | 14:27 ET | [SCHEDULE 13D](/filings/0002161822-26-000002.md) | Ownership report, active investor | 0002161822-26-000002 | | 2026-10-22 | 18:35 ET | [SCHEDULE 13D/A](/filings/0000902664-26-004256.md) | Ownership report, active investor, amended | 0000902664-26-004256 | | 2026-10-22 | 12:32 ET | [8-K](/filings/0001628280-26-066829.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-066829 | | 2026-10-19 | 17:36 ET | [SCHEDULE 13D/A](/filings/0000902664-26-004214.md) | Ownership report, active investor, amended | 0000902664-26-004214 | | 2026-10-15 | 09:08 ET | [8-K](/filings/0001628280-26-065948.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-065948 | | 2026-08-06 | 17:48 ET | [10-Q](/filings/0001628280-26-053602.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053602 | | 2026-08-05 | 16:06 ET | [8-K](/filings/0001628280-26-053316.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053316 | | 2026-08-03 | 12:05 ET | [8-K](/filings/0001628280-26-051635.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-051635 | | 2026-07-23 | 19:30 ET | [SCHEDULE 13D](/filings/0000902664-26-003225.md) | Ownership report, active investor | 0000902664-26-003225 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-017384.md), filed Mar 13, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1680378 - Tickers: SNES - Exchange: Nasdaq - SIC code: 2870 Agricultural Chemicals - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 21:37 ET. No prices; not investment advice.